Emsculpt NEO: How It Works and Does It Work?

Emsculpt NEO is the market name for BTL's BTL-899 device family, which combines radiofrequency with the muscle-stimulation technology used in the original Emsculpt.

One caveat on names: FDA's 510(k) records list model numbers, not brand names, so the link between the BTL-899 family and the Emsculpt NEO name is inferred from BTL being the applicant, the device type and the timing.

BTL markets these devices as Emsculpt NEO.

The original BTL-899 clearance (K192224) came through the 510(k) device pathway on December 5, 2019.

It covers non-invasive lipolysis — the cleared wording is "breakdown of fat" — and reduction in circumference of the abdomen, initially only for skin types I through III.

Later versions added the thighs (BTL-899ST, K202199, 2021) and extended coverage to skin types I through VI (BTL-899 FP, K211107, July 2021).

A September 21, 2023 clearance for the BTL-899F model (K230467) covers the abdomen and thighs for skin types I through VI, lipolysis of the flanks for skin types I through IV, and lipolysis of the upper arms for skin types II and III at a BMI of 30 and under.

That is also the difference from the original device: the Emsculpt-type clearances are for muscle strengthening, toning and firming, and they include no fat-reduction indication, while the fat-reduction clearances belong to this family.

Our Emsculpt guide covers the original device in depth.

In August 2024, BTL also received a 510(k) for a BTL-899MS model (K240234).

Trade press reported it as an Emsculpt NEO clearance for rehabilitative uses — a powered muscle stimulator for uses such as muscle re-education — but the indication wording comes from trade press rather than the clearance summary, so we cannot confirm how it is labeled.

The cleared description is the honest starting point: FDA has cleared the family for non-invasive lipolysis — breakdown of fat — and, for the abdomen and thighs, for reduction in circumference.

Weight loss is not among the cleared indications.

The muscle-stimulation side draws on the same technology cleared in the original Emsculpt-type devices, where the indications are muscle strengthening, toning and firming.

As for the treatment itself, BTL says a session lasts 30 minutes and that the typical protocol is four sessions scheduled 5 to 10 days apart.

BTL also describes the treatment as being for patients up to BMI 35.

On recovery, BTL says there is no downtime and that you can get back to your daily routine right after the treatment.

That is the manufacturer's description, not an independent finding.

BTL advertises Emsculpt NEO results as "25% muscle growth" and "30% fat reduction", figures the company marks as study-based averages.

Said precisely: BTL reports average increases of about 25% in muscle and 30% reduction in fat in its studies.

These are manufacturer marketing figures — the underlying studies are small and mostly BTL-sponsored — not a prediction of what any one person will get.

The peer-reviewed studies in our sources tested the muscle-stimulation technology itself, HIFEM, which sits in both device families.

A 2019 MRI study (Kinney and Lozanova, Lasers in Surgery and Medicine; 22 people; four abdominal treatments) reported an average 18.6% reduction in fat thickness, a 15.4% increase in rectus abdominis muscle thickness, a 10.4% reduction in abdominal separation, and a 3.8 cm average waist reduction at two months.

A 2020 follow-up (Aesthetic Surgery Journal; 21 people; scans about 1 year after HIFEM treatment) reported mean reductions versus baseline of 14.6% in fat, 19.1% in muscle thickening and 10.5% in abdominal separation, with no adverse events reported.

The authors themselves write that durability needs verification.

Read those numbers as what two small studies measured, not what you should expect.

They were small, single-arm studies without a comparison group, and neither one tested the radiofrequency-plus-HIFEM combination by name.

There is no independent verdict, and we will not invent one.

Whether it is worth it depends on what a practice charges you — this page does not quote prices — and on how much the evidence supports the outcome you want.

On the evidence side, the cleared indications are fat breakdown and circumference reduction in specific areas, not weight loss.

The published studies in our sources measured changes in small groups, and the 2020 follow-up's authors write that durability needs verification.

On the marketing side, the 25% and 30% figures are BTL's own study-based averages, not independent findings and not a guarantee.

If you are comparing practices, the concrete questions are:

• Which BTL model is in the office, and which cleared areas and skin-type limits cover the area you want treated?
• What does a package include, measured against BTL's own four-session protocol?
• Which of the practice's claimed results come from BTL, and which from independent studies?
• Does the outcome you want — smaller circumference in a specific area — match what the device is cleared to do?

Emsculpt NEO is a device treatment, so what you are really choosing is a practice: which BTL machine it runs, and how well what it offers matches the clearances.

• Ask which model the practice runs and which cleared areas it covers — lipolysis and circumference reduction of the abdomen and thighs for skin types I through VI, lipolysis of the flanks for skin types I through IV, and of the upper arms for skin types II and III at BMI 30 and under.
• Ask what a package includes; BTL's own protocol is four 30-minute sessions 5 to 10 days apart.
• Ask how the practice describes expected results, and which claims are the maker's rather than independent findings.

For credentials, oversight and the questions worth asking any med spa before you book, our how to choose a med spa guide walks through it step by step.